Log in

NASDAQ:BIS - ProShares UltraShort Nasdaq Biotechnology Stock Price, Forecast & News

$14.66
-0.22 (-1.48 %)
(As of 02/28/2020 04:00 PM ET)
Add
Today's Range
$14.66
Now: $14.66
$15.82
50-Day Range
$12.64
MA: $13.50
$15.01
52-Week Range
$12.58
Now: $14.66
$21.45
Volume226,000 shs
Average Volume117,975 shs
Market Capitalization$21.77 million
P/E RatioN/A
Dividend Yield2.06%
BetaN/A
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in equity securities and derivatives that have similar daily performance characteristics as twice (200%) the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.

Basic Details

Issuer ProShares
Fund NameProShares UltraShort Nasdaq Biotechnology
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:BIS
Inception Date4/6/2010
Fund ManagerMichael Neches, Tarak Dave
Phone+1-240-4976400

Fund Focus

Asset ClassEquity
BenchmarkNasdaq Biotech Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$19.04 million
Average Daily Volume$100,288.40
Discount/Premium0.02%

ETF Expenses

Management Fee0.75%
Other Expenses0.36%
Total Expenses1.11%
Fee Waiver-0.16%
Net Expenses0.95%

Administrator, Advisor and Custodian

AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Transfer AgentJPMorgan Chase Bank, N.A.
Trustee
Lead Market MakerVirtu Financial

Receive BIS News and Ratings via Email

Sign-up to receive the latest news and ratings for BIS and its competitors with MarketBeat's FREE daily newsletter.


Geographic Exposure of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)
Currency Exposure of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Frequently Asked Questions

What is ProShares UltraShort Nasdaq Biotechnology's stock symbol?

ProShares UltraShort Nasdaq Biotechnology trades on the NASDAQ under the ticker symbol "BIS."

How often does ProShares UltraShort Nasdaq Biotechnology pay dividends? What is the dividend yield for ProShares UltraShort Nasdaq Biotechnology?

ProShares UltraShort Nasdaq Biotechnology announced a quarterly dividend on Tuesday, December 24th. Shareholders of record on Thursday, December 26th will be paid a dividend of $0.0413 per share on Thursday, January 2nd. This represents a $0.17 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date of this dividend is Tuesday, December 24th. View ProShares UltraShort Nasdaq Biotechnology's Dividend History.

Has ProShares UltraShort Nasdaq Biotechnology been receiving favorable news coverage?

News stories about BIS stock have trended extremely negative recently, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. ProShares UltraShort Nasdaq Biotechnology earned a daily sentiment score of -4.6 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for ProShares UltraShort Nasdaq Biotechnology.

What other stocks do shareholders of ProShares UltraShort Nasdaq Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares UltraShort Nasdaq Biotechnology investors own include Royal Dutch Shell (RDSB), Standard Chartered (STAN), XCel Brands (XELB), Rogers (ROG), VF (VFC), Autoweb (AUTO), TCG BDC (CGBD), Republic First Bancorp (FRBK), Alphabet (GOOG) and Inpixon (INPX).

Who are ProShares UltraShort Nasdaq Biotechnology's major shareholders?

ProShares UltraShort Nasdaq Biotechnology's stock is owned by many different of institutional and retail investors. Top institutional investors include Wealthsource Partners LLC (5.24%). View Institutional Ownership Trends for ProShares UltraShort Nasdaq Biotechnology.

Which major investors are buying ProShares UltraShort Nasdaq Biotechnology stock?

BIS stock was purchased by a variety of institutional investors in the last quarter, including Wealthsource Partners LLC. View Insider Buying and Selling for ProShares UltraShort Nasdaq Biotechnology.

How do I buy shares of ProShares UltraShort Nasdaq Biotechnology?

Shares of BIS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is ProShares UltraShort Nasdaq Biotechnology's stock price today?

One share of BIS stock can currently be purchased for approximately $14.66.

How big of a company is ProShares UltraShort Nasdaq Biotechnology?

ProShares UltraShort Nasdaq Biotechnology has a market capitalization of $21.77 million. View Additional Information About ProShares UltraShort Nasdaq Biotechnology.

What is ProShares UltraShort Nasdaq Biotechnology's official website?

The official website for ProShares UltraShort Nasdaq Biotechnology is http://www.proshares.com/.

How can I contact ProShares UltraShort Nasdaq Biotechnology?

ProShares UltraShort Nasdaq Biotechnology's mailing address is SUITE 1000, 7501 WISCONSIN AVENUE, Bethesda, MD 20814, United States. The company can be reached via phone at +1-240-4976400.


MarketBeat Community Rating for ProShares UltraShort Nasdaq Biotechnology (NASDAQ BIS)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  60 (Vote Outperform)
Underperform Votes:  91 (Vote Underperform)
Total Votes:  151
MarketBeat's community ratings are surveys of what our community members think about ProShares UltraShort Nasdaq Biotechnology and other stocks. Vote "Outperform" if you believe BIS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BIS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/29/2020 by MarketBeat.com Staff

Featured Article: Recession

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel